Form 4: Health Catalyst COO Daniel LeSueur Sells 11,923 Shares

Health Catalyst's Chief Operating Officer, Daniel LeSueur, sold 11,923 shares of common stock at a price of $6.7151 per share on June 6, 2024, according to a pre-arranged trading plan.

Summary

• On June 6, 2024, Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc. (HCAT), sold 11,923 shares of the company's common stock.
• The sale was executed at a price of $6.7151 per share.
• Following the transaction, LeSueur directly owns 160,423 shares of Health Catalyst stock.
• The sale was conducted under a pre-arranged trading plan adopted on March 7, 2024, in accordance with Rule 10b5-1.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information. However, investors often monitor insider transactions for signals about management's confidence in the company's future prospects.

Stakeholder Impact

• The stock sale by a key executive could be perceived negatively by some shareholders, potentially leading to slight downward pressure on the stock price in the short term.

Key Dates